Central nervous system |
|
|
|
CNS-depression effects |
-- |
Mice |
[30-32] |
Anti-electroconvulsive shock |
50 mg/kg × 7 days |
Rats |
[33] |
Improving memory |
11.25 g/kg Jiannaoning
|
Rats |
[36] |
Cardiovascular system |
|
|
|
Protecting cardiac cell |
20 mg/kg iv; 54,27,13.5 mg/kg |
Dogs; rats |
[39,40] |
Preventing coronary vascular dysfunction |
120 mg/kg |
Rats |
[41] |
Antagonizing (NE, KCl, CaCl2) effects |
0.03-3 mg/min |
Rabbits; guinea pigs |
[42,43] |
Anti-CHD effects |
-- |
Patients |
[44] |
Effects on ANP gene expression |
50 mg/kg × 7 d |
Rats |
[45,46] |
Effects on Growth and metabolism |
|
|
|
Increasing body weight |
-- |
Young mice and rats |
[32] |
Effects on lipid metabolism |
-- |
Hyperlipidemic mice |
[47] |
Regulating lipid metabolism |
60 mg/kg |
Rabbits |
[48] |
Anti-hyperglycemic effects |
|
|
|
Anti-diabetic effects |
-- |
Diabetic patients |
[49] |
Anti-hyperglycemic effects |
-- |
Mice, rats |
[58] |
Lowering blood glucose |
150 mg/kg × 12 d |
ob/ob mice |
[21] |
Increasing blood insulin |
-- |
Mice; rats |
[60] |
Hypoglycemic activities |
200 mg/kg × 12 d |
ob/ob mice |
[61] |
Anti-obesity activities |
|
|
|
Decreasing body weight |
150 mg/kg × 12 d |
ob/ob mice |
[21,61] |
Anti-cancer effects |
|
|
|
Anti-prostate, bladder and renal cancer |
-- |
Patients |
[63] |
Killing cancer cells via at least 5 pathways |
-- |
Normal and cancer cells |
[64] |
Reducing apoptotic cell number |
60-140 mg/kg |
Mouse cells |
[65] |
Anti-oxidant activity |
|
|
|
Suppressing antioxidant enzyme activity |
40-200 mg/kg |
Diabetic rats |
[69] |
Antioxidant property in cardiac cells |
0.25-1 mg/ml |
Rat cultured cardiac cells |
[8] |
Restoring free radical-damaged cells |
30 μg/ml (Rb1,2,3) |
Cultured myocardiomyocytes |
[72] |
Other pharmacological effects |
|
|
|
Anti-fatigue |
100/200 mg/kg |
Rats |
[73] |
Anti-ulcer |
100 mg/kg |
Mice |
[6] |
Anti-diuretic |
-- |
Rats |
[31] |
Anti-aging |
-- |
Patients |
[74] |
Anti-foot-and-mouth disease |
10 μg* +oil emulsion |
Mice |
[76] |